The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
about
In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes.High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial.Targeting the vascular endothelial growth factor in hematologic malignancies.VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis.Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C.Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical HoPretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma.Vascular endothelial growth factor protein expression is associated with a poor prognosis in patients with cutaneous extranodal natural killer/T-cell lymphoma.VEGF-C: putting the 'lymph' back in lymphoma?
P2860
Q33701036-393C2F7D-B703-4B1F-A452-CE4CD71B4EDEQ33978922-554D7E7A-06A5-4129-90CF-C0A5E2C7C3B3Q35082512-1879BE92-A205-40AB-80B6-35474D4E928DQ37573849-CC74BACB-31AB-4677-A92B-DE215BA1DA22Q38038645-E898C5BC-1881-44CD-8F3F-63C9261DCBB4Q38391574-F32AD323-F782-4899-8B5C-89B73720BB02Q38968332-C973B067-3580-407E-B6F5-562A172F7359Q41953798-67281717-92C5-4564-A04C-7B515D066B64Q42160346-5F7A10B3-F727-4B2C-8F02-684B49B118E4Q43883383-0B35CBCE-86D8-4F01-8BAF-EF3080B3587CQ45849297-ECE0F788-E0A9-456F-B8C0-8EA74CC85122Q46193990-78ACFADC-CAE1-441D-ADCB-C2A59D191A38Q47732322-BF0C00BA-E878-4246-AA8C-959828AA5110Q48298653-B450019F-7807-4311-9449-DBF4F79B36A6Q51733975-0F2A8086-3031-41A9-B7D6-998F0E5A8729
P2860
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@en
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@nl
type
label
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@en
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@nl
prefLabel
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@en
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@nl
P2093
P2860
P1433
P1476
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas.
@en
P2093
Gulsah Seydaoglu
Melek Ergin
Semra Paydas
Seyda Erdogan
Sinan Yavuz
P2860
P304
P356
10.1080/10428190802706665
P577
2009-03-01T00:00:00Z